Rathbones Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $557K | Hold |
1,251
| – | – | ﹤0.01% | 419 |
|
|
2025
Q1 | $607K | Sell |
1,251
-203
| -14% | -$98.4K | ﹤0.01% | 391 |
|
|
2024
Q4 | $586K | Hold |
1,454
| – | – | ﹤0.01% | 397 |
|
|
2024
Q3 | $676K | Buy |
1,454
+355
| +32% | +$165K | ﹤0.01% | 373 |
|
|
2024
Q2 | $515K | Sell |
1,099
-570
| -34% | -$267K | ﹤0.01% | 411 |
|
|
2024
Q1 | $698K | Buy |
1,669
+179
| +12% | +$74.8K | ﹤0.01% | 368 |
|
|
2023
Q4 | $606K | Buy |
1,490
+227
| +18% | +$92.4K | ﹤0.01% | 370 |
|
|
2023
Q3 | $439K | Buy |
+1,263
| New | +$439K | ﹤0.01% | 417 |
|